Kevin Brennan
Chief Accounting Officer
Xilio Therapeutics, Inc. (XLO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-03-30–present
-
Current
2023-03-30–present
-
Xilio Therapeutics, Inc. (XLO)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Recent activity
No earnings-call appearances or filed executive changes recorded yet.